Roche

News

Roche bulks up in inflammation with €380m Inflazome acquisit...

Roche has made a second acquisition in the area of NLRP3 inhibitors for inflammatory diseases, buying Irish biotech Inflazome a couple of years after snapping up

News

NICE’s track record in cancer drugs: the impact of the CDF and the role of interim funding

Immunomedics wows ESMO with breast cancer data reveal

Immunomedics has revealed the trial data that convinced Gilead to stage a

White Papers

Preparing for a decade of radical change in pharma

Transformational value - preparing for a decade of radical c...

The pharmaceutical industry is at an inflection point, where ground-breaking innovation must be translated into transformational value for patients, healthcare professionals and society.

News

Roche's Actemra cuts chances of COVID-19 ventilator use in p...

Roche’s Actemra may help fight pandemic after all with phase 3 trial results showing it cut the chances of COVID-19 patients, mainly from higher risk minority ethnic backgrounds with pneumo

Events